| dc.contributor.author | Musteaţă, Larisa | |
| dc.contributor.author | Corcimaru, Ion | |
| dc.contributor.author | Robu, Maria | |
| dc.contributor.author | Musteaţă, Vasile | |
| dc.contributor.author | Oleinicova, Elena | |
| dc.contributor.author | Buruiană, Sanda | |
| dc.contributor.author | Avram, Oxana | |
| dc.date.accessioned | 2019-06-25T21:56:07Z | |
| dc.date.available | 2019-06-25T21:56:07Z | |
| dc.date.issued | 2012 | |
| dc.identifier.citation | MUSTEAŢĂ, Larisa, CORCIMARU, Ion et al. Aspectele clinice şi de tratament ale purpurei trombocitopenice idiopatice. In: Anale ştiinţifice ale USMF “Nicolae Testemiţanu”. Ed. a 13-a. Chişinau: СEP Medicina, 2012, Vol. 3: Probleme actuale în medicina internă, pp.309-313. | en_US |
| dc.identifier.uri | https://repository.usmf.md/handle/20.500.12710/4903 | |
| dc.description | Catedra Hematologie şi Oncologie a U.S.M.F. „N. Testemiţanu” (şeful catedrei – prof. univ., dr.hab.şt.med. I. Corcimaru), IMSP Institutul Oncologic (director – prof., dr.hab.şt.med. V. Cernat) | en_US |
| dc.description.abstract | The aspects of the clinical evolution, diagnosis and treatment of the idiopathic thrombocytopenic purpura were studied in 50 patients. It has been established that the disease developed mostly in young females. The hemorrhagic syndrome had the microcirculatory petechial-echymotic pattern. Although the direct clinico-hematologic response to the treatment with corticosteroid hormones was registered in 86% of patients, in all cases the platelets count decreased within the next 3 – 5 months up to the initial values. Splenectomy allowed to аchieve the recovery in 84% of patients. Particularităţile evoluţiei clinice, diagnosticului şi tratamentului purpurei trombocitopenice idiopatice au fost studiate la 50 pacienţi. A fost stabilit că maladia mai frecvent s-a dezvoltat la femei de vîrstă tînără. Sindromul hemoragic trombocitopenic a avut un caracter microcirculator peteşial-echimatos. Deşi răspunsul clinico-hematologic nemijlocit la tratamentul cu corticosteroizi a fost înregistrat la 86% de pacienţi, în toate cazurile peste 3 – 5 luni numărul trombocitar a scăzut pînă la valorile iniţiale. Splenectomia a permis de a obţine vindecare la 84% de pacienţi. | en_US |
| dc.language.iso | ro | en_US |
| dc.publisher | CEP "Medicina" | en_US |
| dc.title | Aspectele clinice şi de tratament ale purpurei trombocitopenice idiopatice | en_US |
| dc.title.alternative | Clinical and management aspects of the idiopathic thrombocytopenic purpura | en_US |
| dc.type | Article | en_US |